Cytochrome P450 1B1: A major P450 isoenzyme in human blood monocytes and macrophage subsets

Biochemical Pharmacology

Volumn 56, Issue 9, 1998, Pages 1105-1110

  Baron, Jens M ^a   Zwadlo Klarwasser, Gabriele ^a   Jugert, Frank ^a   Hamann, Wilfried ^a   Rübben, Albert ^a   Mukhtar, Hasan ^b   Merk, Hans F ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CYP1B1; Cytochrome P450; Macrophages; Monocytes

Indexed keywords

ALCOHOL; BENZ[A]ANTHRACENE; CYCLOSPORIN A; CYTOCHROME P450; DEXAMETHASONE; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHENOBARBITAL; PHORBOL 13 ACETATE 12 MYRISTATE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MONOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031772143     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00105-1     Document Type: Article

References (42)

1. Merk H, and Hertl M, Immunologic mechanisms of cutaneous drug reactions. Seminars in Cutaneous Medicine and Surgery 15: 228-235, 1996.
2. Merk H, Schneider R, and Scholl P, Lymphocyte stimulation with drug-modified microsomes. In: Toxicological and Immunologic Aspects of Drug Metabolism and Environmental Chemicals (Eds. Estabrook RW, Lindlaub E, Oesch F and de Weck AL), pp. 211-220. Schattauer, Stuttgart, 1987.
3. Basketter DA, Pendlington RU, Sarll A, and Scholes E, The role of P4501A1 in the activation of prohaptens in skin sensitization. J Invest Dermatol 106: 915A, 1996.
4. Fujino T, Park SS, and Gelboin HV, Phenotyping of cytochrome P-450 in human tissue with monoclonal antibodies. Proc Natl Acad Sci USA 79: 3682-3686, 1982.
5. Germolec DR, Adams NH, and Luster MI, Comparative assessment of metabolic enzyme levels in macrophage populations of the F344 rat. Biochem Pharmacol 50: 1495-1504, 1995.
6. Boyum A, Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J Clin Lab Invest 21: 77-89, 1968.
7. Zwadlo G, Bröcker EB, von Bassewitz DB, Feige U, and Sorg C, A monoclonal antibody to differentiation antigen present on mature human macrophages and absent from monocytes. J Immunol 134: 1487-1492, 1985.
8. Kumagai K, Pretreatment of plastic dishes with FCS. A simple method for macrophage isolation. J Immmunol Method 29: 17-25, 1979.
9. Zwadlo G, Schlegel R, and Sorg C, A monoclonal antibody to a subset of human monocytes found only in the peripheral blood and inflammatory tissues. J Immunol 137: 512-519, 1986.
10. Zwadlo G, Voegeli R, Schulze-Osthoff K, and Sorg C, A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp Cell Biol 55: 295-302, 1987.
11. Miltenyi S, Müller W, Weichel W, and Radbruch A, High gradient magnetic cell separation with MACS. Cytometry 11: 231-238, 1990.
12. 30-latex. Nucl Acids Res Symp Series 19: 61-64, 1988.
13. Hakkola J, Fasanen M, Purkunen R, Saarikoski S, Pelkonen O, Mäenpää J, Rane A, and Raunio H, Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol 48: 59-64, 1994.
14. Feinberg AP, and Vogelstein B, A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13, 1983.
15. Towbin H, Straehlin T, and Gordon J, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Nad Sci USA 72: 4350-4354, 1979.
16. Zwadlo G, Brüggen J, Gerhard G, Schlegel R, and Sorg C, Two calcium binding proteins are associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin Exp Immunol 72: 510-515, 1988.
17. Alexander DL, Elton SE, and Jefcoate CR, Ah receptor regulation of CYP1B1 expression in primary mouse embryo-derived cells. Cancer Research 57: 4498-4506, 1997.
18. Battenger LH, Christou M, and Jefcoate CR, Purification and immunologic characterization of a novel cytochrome P450 from C3H10T1/2 cells. Arch Biochem Biophys 286: 488-497, 1991.
19. Stoilov I, Akarsu AN, and Sarfarazi M, Identification of three different truncated mutations in cytochrome P4501B1 (CYP1B1) as the principle cause of primary congenital glaucoma. Hum Mol Genet 6: 641-647, 1997.
20. Cantfort JV, deGraeve J, and Gielen JF, Radioactive assay for aryl hydrocarbon hydroxylase: Improved method and biologic importance. Biochem Biophys Res Commun 70: 505-512, 1977.
21. Nash T, The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem 55: 416-421, 1953.
22. Jugert F, Agarwal R, Kuhn A, Bickers RR, Merk HF, and Mukhtar H, Multiple cytochrome P450 isoenzymes in murine skin: Induction of P4501A, 2B, 2E, and 3A by dexamethasone. J Invest Dermatol 102: 970-975, 1994.
23. Koop DR, Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P450 isozyme 3a. Mol Pharmacol 29: 399-404, 1986.
24. Bhardwaj RS, Zotz C, Zwadlo-Klarwasser G, Roth J, Goebeler M, Mahnke K, Falk M, Meinardus-Hager G, and Sorg C, The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions. Eur J Immunol 22: 1891-1897, 1992.
25. Hamann W, Flöter A, Schmutzler W, and Zwadlo-Klarwasser G, Characterization of a novel anti-inflammatory factor produced by RM3/1 macrophages derived from glucocorticoid-treated human monocytes. Inflamm Res 44: 535-540, 1995.
26. Sutter TR, Tang YM, Hayes CL, Wo YP, Jabs W, Li X, Yin H, Cody CW, and Greenlee WF, Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 269: 13092-13099, 1994.
27. Tang YM, Wo YP, Stewart J, Hawkins AL, Griffin CA, Sutter TR, and Greenlee WF, Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem 271: 28324-28330, 1996.
28. Hakkola J, Pasanen M, Pelkonen O, Hukkanen J, Evisalmi S, Anttila S, Rane A, Mätylä M, Purkunen R, Saarikoski S, Tooming M, and Raunio H, Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 18: 391-397, 1997.
29. Kress S and Greenlee WF, Cell-specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Res 57: 1264-1269, 1997.
30. Murray GI, Taylor MC, McFadyen CE, McKay JA, Greenlee WF, Burke MD, and Melvin WT, Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57: 3026-3031, 1997.
31. Stein M and Keshav S, The versarility of macrophages. Clin Exp Allergy 22: 19-27, 1992.
32. Nebert DW, Growth signal pathways. Nature 347: 709-710, 1990.
33. Murray GI, and Burke DM, Immunohistochemistry of drug-metabolizing enzymes. Biochem Pharmacol 50: 895-903, 1995.
34. Park BK, Kitteringham NR, Pirmohamed M, and Tucker GT, Relevance of induction of human drug-metabolizing enzymes: Pharmacological and toxicological implications. Br J Clin Pharmacol 41: 477-491, 1996.
35. Rannug A, Alexandrie AK, Persson I, and Ingelman Sundberg M, Genetic polymorphism of cytochrome P450 1A1, 2D6 and 2E1: Regulation and toxicological significance. J Occup Environ Med 37: 25-36, 1995.
36. Meyer UA, and Zanger UM, Molecular mechanisms of polymorphism of drug metabolism. Ann Rev Pharmacol Toxicol 37: 269-296, 1997.
37. Kawakubo Y, Nakamori M, Schöpf E, and Ohkido M, Acetylator phenotype in patients with p-phenylendiamine (PPD) allergy. Dermatology 195: 43-45, 1997.
38. Dietrich A, Kawakubo Y, Rzany B, Mockenhaupt M, Simon JC, and Schopf E, Low N-acetylating capacity in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Exp Dermatol 4: 313-316, 1995.
39. Wolkenstein P, Carrière V, Charue D, Bastuji-Garin S, and Revuz J, A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome. Pharmacogenetics 5: 255-258, 1995.
40. Martin S, and Weltzien HU, T cell recognition of haptens, a molecular view. Int Arch Allergy Immunol 104: 10-15, 1994.
41. Park BK, Coleman JW, and Kitteringham NR, Drug disposition and drug hypersensitivity. Biochem Pharmacol 36: 581-587, 1987.
42. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, and Sutter TR, Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res 56: 2979-2984, 1996.